您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
MCP-1/CCL2 Protein, Human

MCP-1/CCL2 Protein, Human

货号: UA040175
价格: 1000
规格: 10μg
介绍: -
其他: -
产品规格
  • 物种

    Human
  • 分子别名

    C-C motif chemokine 2; HC11; Monocyte chemoattractant protein 1; Monocyte chemotactic and activating factor (MCAF); Monocyte chemotactic protein 1 (MCP-1); Monocyte secretory protein JE; Small-inducible cytokine A2;
  • Accession

    P13500
  • 表达序列

    Gln24-Thr99
  • 表达宿主

    E.coli
  • 分子量

    8.7 kDa (Reducing)

  • 纯度

    >95% by SDS-PAGE

  • 内毒素含量

    <0.1EU/μg
  • 活性

    Test in progress
  • 标记

    Unconjugated
  • 标签

    No Tag
  • 性状

    Lyophilized Powder
  • 缓冲体系

    20mM Tris, 500mM NaCl, pH8.0
  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
  • 文献引用

    1. Cytokine Growth Factor Rev. 2010 Feb;21(1):41-8.  Epub 2009 Dec 14.

  • 稀释度

背景介绍
  • MCP-1, also known as CCL2, is a chemokine belonging to the C-C chemokine family. It plays a crucial role in various physiological processes such as inflammation, immune regulation, and cell migration. MCP-1/CCL2 primarily functions by binding to the C-C chemokine receptor CCR2, thereby guiding monocytes and other inflammatory cells to migrate to sites of inflammation, contributing to the inflammatory response and immune regulation.

    Overexpression of MCP-1/CCL2 is closely associated with the pathogenesis and progression of various diseases, including inflammatory diseases, autoimmune disorders, cancer, and metabolic disorders. As a result, MCP-1/CCL2 has emerged as a potential therapeutic target, and researchers are exploring therapeutic strategies targeting MCP-1/CCL2 in the hope of impacting the treatment of related diseases.

  • 电泳JSON

    • g (R: reducing condition, N: non-reducing condition).